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Four Residues of the Extracellular N-Terminal
Domain of the NR2A Subunit Control
High-Affinity Zn21 Binding to NMDA Receptors
gating mechanism itself, remain poorly understood. We
have begun to look at the structural determinants of one
such modulation, the voltage-independent inhibition by
extracellular Zn21 ions, and have identified several resi-
dues that are closely related to Zn21 binding, the first
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NMDA receptors are heteromers consisting of two46 rue d'Ulm
different subunits, NR1 and NR2, that share a common75005 Paris
membrane topology with all other ionotropic glutamateFrance
receptor subunits. Each subunit contains three trans-² Instituto Cajal
membrane segments (TM1, TM3, and TM4), a P loopConsejo Superior de Investigaciones CientõÂficas
region (called TM2, according to the originally proposed28002 Madrid
topology), and a cytoplasmic C terminus (see DingledineSpain
et al., 1999). The extracellular domains are made by the
large N-terminal region (z550 amino acids) preceding
TM1 and by a smaller loop (z150 amino acids) betweenSummary
TM3 and TM4. The first part of the N terminus (the first
380 amino acids) has a weak sequence similarity withNMDA receptors are allosterically inhibited by Zn21
a bacterial periplasmic protein called LIVBP (for leucine,ions in a voltage-independent manner. The apparent
isoleucine, valine binding protein; O'Hara et al., 1993;affinity for Zn21 of the heteromeric NMDA receptors is
Masuko et al., 1999). The rest of the N terminus, alongdetermined by the subtype of NR2 subunit expressed,
with a portion of the loop between TM3 and TM4, showswith NR2A-containing receptors being the most sensi-
sequence similarity to other bacterial amino acid bindingtive (IC50, z20 nM) and NR2C-containing receptors be-
proteins such as QBP (for glutamine binding protein)ing the least sensitive (IC50, z30 mM). Using chimeras
and LAOBP (lysine, arginine, ornithine binding protein;constructed from these two NR2 subtypes, we show
Nakanishi et al., 1990; O'Hara et al., 1993; Stern-Bachthat the N-terminal LIVBP-like domain of the NR2A
et al., 1994). This second extracellular domain has beensubunit controls the high-affinity Zn21 inhibition. Muta-
shown to make up the agonist binding site with specific-tions at four residues in this domain markedly reduce
ity for glycine in the NR1 subunits and for glutamate inZn21 affinity (by up to .500-fold) without affecting ei-
the NR2 subunits (see Dingledine et al., 1999).ther receptor activation by glutamate and glycine or
Extracellular Zn21 induces two types of inhibitory ef-inhibition by extracellular protons and Ni21 ions, indi-
fects on NMDA receptors, a voltage-dependent channelcating that these residues most likely participate in
block much like the one produced by Mg21 ions and ahigh-affinity Zn21 binding.
voltage-independent inhibitionÐhereinafter referred to
as inhibitionÐdue to a decrease in the open probability
Introduction of the receptor channel (Christine and Choi, 1990; Le-
gendre and Westbrook, 1990). Previous studies on re-
Channel gating, along with ionic selectivity, constitutes combinant receptors showed that voltage-independent
one of the two fundamental properties that define the Zn21 inhibition is primarily determined by the type of
physiological role of an ion channel. It is therefore not NR2 subunit present (Williams, 1996; Chen et al., 1997;
surprising that the gating properties of ion channels are Paoletti et al., 1997; Traynelis et al., 1998). Receptors
often the target of allosteric modulators. NMDA recep- containing NR2A subunits have a high sensitivity to Zn21
tors, members of the ionotropic glutamate receptor fam- (IC50, z20 nM), and the inhibition is partial, allowing
ily that have been implicated in neuronal development z20% of the channels to remain active at saturating
and synaptic plasticity, as well as pathological disor- Zn21 concentrations, whereas the receptors containing
ders, constitute a typical example of heavily modulated other NR2 subunits (2B, 2C, or 2D) have a lower sensitiv-
channels. Their activation requires the presence of two ity to Zn21 (IC50 ranging between 0.5 mM for NR2B and
coagonists, glutamate and glycine, and their gating is 30 mM for NR2C), and the inhibition is complete at high
affected by several extracellular agents, including pro- concentrations of Zn21. As a consequence of their high
tons, several divalent cations, and polyamines, which Zn21 sensitivity, NR2A-containing receptors are ex-
act noncompetitively with respect to the agonists (re- pected to be tonically inhibited by the low levels of Zn21
viewed by McBain and Mayer, 1994; Dingledine et al., (usually .50 nM) found as contaminants in standard
1999). For each of these modulators, there must exist solutions in most laboratories. Indeed, application of
a binding site and transduction machinery linking the heavy metal chelators potentiates NR1-NR2A receptors,
binding site to the ªgate.º However, the molecular struc- presumably by removing the contaminating Zn21 (Pao-
tures underlying the binding of these modulators and letti et al., 1997).
their link with the gating mechanism, as well as the In characterizing the mechanism of Zn21 inhibition, an
important step is to locate precisely where the inhibiting
Zn21 ions bind on the NMDA receptor. In this study, we³ To whom correspondence should be addressed (e-mail: neyton@
biologie.ens.fr). concentrated on the high-affinity Zn21 binding site found
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specifically in NR2A-containing receptors. Given that
this inhibition by Zn21 showed no sensitivity to voltage,
our starting hypothesis was that the high-affinity Zn21
inhibitory site should be located in the extracellular do-
mains of the NR2A subunit. We began by roughly locat-
ing this site within the NR2A extracellular domains using
receptors containing chimeric NR2 subunits made from
NR2A and NR2C, coexpressed with NR1 in Xenopus
oocytes. Measurements under two-electrode voltage
clamp of the Zn21 inhibition in various chimeras allowed
the identification of an N-terminal region of z380 amino
acids as being necessary for high-affinity Zn21 binding.
Interestingly, this region coincides with the LIVBP-like
region. Next, using a point mutation strategy, we identi-
fied four residues in this N-terminal domain that may
represent, at least in part, the molecular determinants
of the high-affinity Zn21 binding site. Mutations at these
residues markedly decrease (.50-fold) the apparent af-
finity for Zn21 of NR2A-containing receptors, and they
specifically target the high-affinity Zn21 inhibition: nei-
ther the apparent affinities for either agonist nor other
types of gating modulation, such as those by protons
or Ni21, are affected. While this work was in progress,
another study proposed that two residues in the N-termi-
nal region of the NR2A subunit (including one of the
residues discussed in this report) may constitute part
of the Zn21 binding site (Choi and Lipton, 1999).
Results
A Major Molecular Determinant of the High-Affinity,
Voltage-Independent Zn21 Inhibition Resides
in the N-Terminal LIVBP-like Domain
of the NR2A Subunit
Given the subunit specificity and voltage independence
of the Zn21 inhibition, we restricted our search for the
high-affinity Zn21 binding site to the extracellular region
of the NR2A subunit. To locate which part of this large
Figure 1. The N-Terminal Region Preceding the TM1 Segment ofregion (.500 amino acids) is most likely to contain the
the NR2A Subunit Confers High-Affinity Zn21 Inhibition to NMDAhigh-affinity Zn21 binding site, we measured the Zn21
Receptorssensitivity of receptors consisting of NR1 subunits coex-
(A) Current responses induced by applications of 100 mM of gluta-pressed with chimeric subunits made by swapping dif-
mate and glycine in oocytes expressing NMDA receptors containingferent regions between the most sensitive subunit,
wild-type NR2A (A1), wild-type NR2C (A2), or chimeric NR2A/NR2C
NR2A, and the least sensitive one, NR2C. Figure 1 com- subunits (A3 and A4). The recordings were made at 260 mV either
pares Zn21 inhibition observed with wild-type NR2A or in the presence of 50 nM buffered Zn21 (asterisk) or in the absence
of Zn21 (10 mM DTPA in the bath). The bar above the current tracesNR2C subunits with that observed with chimeras in
indicates agonist application. A schematic diagram of the NR2 con-which the region N-terminal to TM1 from one subunit
struct is shown in each panel using white and black for NR2A andhas been replaced by the homologous region from the
NR2C regions, respectively.other subtype. At a steady voltage of 260 mV, an appli-
(B) Zn21 dose±response curves of the constructs shown in (A). To
cation of 50 nM buffered Zn21 (see Experimental Proce- avoid contamination of the Zn21 voltage-independent inhibition by
dures), a concentration too low to produce a voltage- Zn21 voltage-dependent block, all current measurements were made
at the end of a 4 s voltage ramp from 2100 mV to 150 mV. Thedependent block of NMDA receptors (Paoletti et al.,
relative current is the ratio between leak-subtracted currents re-1997), induces a strong inhibition (z62%) of the re-
corded in the presence and absence of Zn21, respectively. Zn21 wassponse evoked by saturating doses of glutamate and
buffered using 10 mM tricine for [Zn] # 1 mM (see Experimentalglycine (100 mM each) in wild-type NR2A-containing re-
Procedures). Experimental points were fitted using equation 1 (solid
ceptors (Figure 1A1). By contrast, wild-type NR2C-con- lines). Parameters of the fits are given in the text.
taining receptors are barely inhibited at this concentra-
tion (Figure 1A2). The Zn21 sensitivity of the receptors
containing chimeric subunits depends on the donor of chimeras with the N terminus of NR2A, such as NR2A/
C(553) (see Figure 1A4), are strongly inhibited (z55%).the pre-TM1 N-terminal region. Thus, receptors con-
taining chimeras with the N terminus of NR2C, such as Full Zn21 dose±inhibition curves (Figure 1B) were ob-
tained for these four NR2 constructs in a series of experi-NR2C/A(564) (see Figure 1A3), are only slightly, if at all,
inhibited by 50 nM Zn21, whereas receptors containing ments performed with 2100/150 mV voltage ramps (see
High-Affinity Zn21 Binding Site in NMDA Receptors
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Figure 2. The High-Affinity Zn21 Binding Site
Can Be Localized to the LIVBP-like Domain
of the N Terminus of NR2A Receptors
The left-hand side of the figure shows sche-
matic diagrams of different chimeric and de-
letion constructs of the NR2 subunit. The pre-
cise location of the fragments' borders is
given in the Experimental Procedures sec-
tion. Apparent Zn21 affinities (IC50s), mea-
sured with receptors containing each of the
constructs (mean of at least three indepen-
dent determinations), is shown on the right.
The region within 65-fold of the mean appar-
ent affinity of wild-type NR1-NR2A receptors
is indicated by the hatched bar.
Experimental Procedures). The current was measured The top four rows plot the results obtained with the
constructs of Figure 1. Data from chimeras in which oneat 150 mV to avoid contamination of the voltage-inde-
pendent inhibition by the voltage-dependent Zn21 block of segments N1±N6 had been replaced by the homolo-
gous region of NR2C or deleted altogether are shownin the 1 mM±1 mM concentration range. Experimental
data were fitted by a Michaelis inhibition function (see in rows 6±12, and NR2A9, the parental NR2A from which
each of these chimeras was constructed, is shown inExperimental Procedures). The curve obtained with
NR2A/C(553) chimera-containing receptors resembles row 5. NR2A9 had an IC50 of 29 nM, which is very close
to the IC50 of NR2Awt. In contrast, chimeras involvingthat of receptors containing NR2Awt subunits in that
the IC50 for both receptors is in the 10±100 nM range N1, N2, and N3 regions all present a markedly increased
(.50-fold) Zn21 IC50. The Zn21 IC50s of chimeras involving[67 nM for NR2A/C(553) and 14 nM for NR2Awt], and
they saturate at 75% maximum inhibition. On the other regions more proximal to TM1 are either only moderately
increased (by 10-fold in the case of N6), not significantlyhand, receptors containing the chimera NR2C/A(564)
are similar to NR2Cwt in IC50 values [6.7 mM for NR2C/ affected (N5), or even decreased (by 55-fold in the case
of N4).A(564) versus 23 mM for NR2C] as well as maximal inhibi-
tion (close to 100% in both cases). These results show Taken together, these results suggest that the high-
affinity Zn21 binding site may be located in the N1±N3that high-affinity Zn21 inhibition requires the presence
of the region of NR2A preceding TM1. regions. This idea is supported by the observation that
the subunit NR2C(AN1±4), formed by replacement ofNext, using a set of NR2A/NR2C chimeras (see Experi-
mental Procedures for a precise definition of the chime- segments N1±N4 in NR2C by the homologous region of
NR2A, is highly sensitive to Zn21 (Figure 2, row 13).ras), we attempted to localize the high-affinity Zn21 bind-
ing site to a smaller region of the NR2A N terminus. Interestingly, the region consisting of the segments
N1±N3 has been shown to share sequence similarityBriefly, the N-terminal region of NR2 subunits was subdi-
vided into six regions numbered N1±N6, and each of with one type of bacterial periplasmic protein, the LIVBP
(O'Hara et al., 1993; Masuko et al., 1999). We will herein-these regions was replaced in NR2A by the homologous
fragment of NR2C. All of these constructs, except after call this region the LIVBP-like domain.
While the exchange of the N2 or N3 regions reducedNR2A9(CN1), resulted in functional NR2 subunits, as indi-
cated by the amplitude of the glutamate responses re- the apparent affinity for Zn21 by at least 50-fold, the Zn21
inhibition was not abolished, and the resulting receptorscorded in oocytes (see Experimental Procedures). To
study the potential implication of the N1 region in the were still sensitive to micromolar concentrations of Zn21.
One possibility is that the LIVBP-like domains in NR2Ahigh-affinity Zn21 binding site, this region was split into
two smaller fragments (N1a and N1b), which were de- and NR2C contain amino acid residues that contribute
to a high-affinity Zn21 binding site in NR2A and a lowleted one at a time in NR2A instead of being replaced
by the homologous NR2C fragments, leading to the affinity site in NR2C such that replacement of fragments
in NR2A with homologous fragments of NR2C switchesfunctional constructs NR2A9(DN1a) and NR2A9(DN1b),
respectively. Zn21 inhibition was measured at 150 mV the sensitivity of the resulting receptor to an NR2C-like
sensitivity. A strong argument against this possibility isfor each of the chimeric constructs, and the IC50 values
were obtained from the dose±inhibition curves. The re- that receptors containing the construct NR2A9(DN1±3)tr
(Figure 2, row 14), in which the full LIVBP-like domain hassults from these experiments are plotted in Figure 2.
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Figure 3. Mutagenesis Scans to Identify Res-
idues Important for Zn21 Binding
Alignment of NR2A, NR2B, NR2C, and NR2D
sequences has been taken from Ishii et al.
(1993). The N-terminal signal sequences are
omitted. Putative Zn21 ligands of the high-
affinity Zn21 binding site (H, C, D, or E resi-
dues that were present in NR2A but not con-
served at homologous positions in NR2C)
were mutated in the first mutagenesis series
(triangles). A second mutagenesis scan was
performed through the NR2A LIVBP-like do-
main to target putative Zn21 coordinating res-
idues that were conserved between NR2A
and NR2C subunits (diamonds). Some posi-
tively charged NR2A residues have also been
mutated in that series. Bold residues indicate
positions where mutations moderately af-
fected Zn21 inhibition (see text). Boxed resi-
dues indicate positions where mutations re-
sulted in a strong effect on the apparent Zn21
affinity.
been deleted, still retain a Zn21 IC50 in the low micromolar made at positions that were occupied by a putative Zn21
ligand (i.e., H, C, D, or E) in NR2A but that were notrange. We were particularly worried that such a large
deletion in an NR2 subunit will produce a nonfunctional conserved (even in a broad degenerate way, i.e., as polar
or charged) in the homologous NR2C position (Figure 3,subunit and that the phenotype observed with this dele-
tion construct might correspond to that of ªhomomericº triangles). We also considered the possibility that the
high-affinity Zn21 binding site may contain residues thatNR1 receptors (see Experimental Procedures). How-
ever, coinjection into oocytes of NR1 with NR2A9(DN1± are conserved between NR2A and NR2C but that, be-
cause of differences in the local environment, may not3)tr leads to large glutamate responses (.1 mA at 260
mV, similar to those recorded with wild-type NR2A), serve this function in NR2C or that, because of the ab-
sence of other partners, may not be sufficient to makeindicating that this NR2 construct is functional.
a high-affinity binding site in NR2C. Therefore, a second
series of mutations were carried out to replace someIdentification of Individual Residues Important
for High-Affinity Zn21 Inhibition conserved C, D, and E residues (Figure 3, diamonds).
In this series, we also mutated some positively chargedThe results from the chimeric receptors described above
suggested the presence of major determinants of the residues (K and R) which, in addition to a possible (but
difficult to test) influence on the Zn21 binding site three-high-affinity Zn21 binding site within the extracellular
LIVBP-like domain in the N terminus of NR2A. Our next dimensional structure, may also exert electrostatic re-
pulsion on the Zn21 cation.strategy was to use point mutations to try to identify
individual amino acid residues that may be important Mutants were screened by measuring the level of inhi-
bition at two Zn21 concentrations: 50 nM, a concentra-for high-affinity Zn21 inhibition. In most proteins, heavy
metal ions are usually coordinated by nitrogen, sulfur, or tion 3-fold higher than the IC50 of NR2Awt-containing
receptors, and 500 nM, a saturating concentration foroxygen atoms found in side chains of histidine, cysteine,
aspartate, and glutamate residues (Glusker, 1991), mak- these receptors (Table 1). We arbitrarily considered as
ªstronglyº affected those mutants that had relative cur-ing these residues logical targets for mutagenesis.
Based on an analysis of published NR2 sequence align- rent amplitudes that were larger than the relative cur-
rents of wild-type receptors by .2-fold (bold and boxedments (Ishii et al., 1993), a first series of mutations were
High-Affinity Zn21 Binding Site in NMDA Receptors
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Table 1. Screening Mutations for Effects on High-Affinity Zn21
Inhibition
Relative Current, Relative Current,
NR2A Construct 50 nM Zn (%) 500 nM Zn (%) n
wt 43 6 6 30 6 5 31
H42A 79 6 2 41 6 3 3
H44A 99 6 1 78 6 3 3
D45N 45 6 5 32 6 5 3
E48A-R49A-E50Q 43 6 2 29 6 3 3
D78A 80 6 3 52 6 6 3
H85S 34 6 5 26 6 5 3
C87A 51 6 7 38 6 7 2
D88S 39 6 6 26 6 6 3
H96A 42 6 3 27 6 3 5
H128S 99 6 1 92 6 2 3
Q163E-D164E 46 6 5 31 6 4 3
H168A 38 6 4 25 6 3 6
Figure 4. Strong Mutations Cause Large Shifts in Zn21 AffinityD182S 37 6 1 28 6 2 3
Zn21 dose±response curves obtained in oocytes expressing NMDAD192N 42 6 6 34 6 7 3
receptors containing strong NR2A mutants. Relative currents wereD207A 77 6 1 52 6 1 3
measured at 150 mV, as indicated in Figure 1B. The values for theE211Q 64 6 2 44 6 3 5
IC50, maximal inhibition and Hill coefficient obtained from the fits forD212N 39 6 2 32 6 1 3
each of the mutants, are given in Table 2.K214A 35 6 7 31 6 6 3
H223G 40 6 7 27 6 4 6
C231A 45 6 3 30 6 3 3
K233R 100 6 1 90 6 5 3 and E266S), and the parameters of the fits, performed
K233S 93 6 3 81 6 3 3 with equation 1 (see Experimental Procedures), are
D234A 36 6 2 26 6 2 4
given in Table 2. The results from the inhibition curvesE235Q 46 6 7 35 6 7 3
confirm our empirical quantitation: the mutations H42A,E242Q 45 6 5 34 6 5 3
R244G 23 6 1 23 6 1 3 D78A, D207A, E211Q, H358A, and K374S moderately
D252N 46 6 5 nd 4 increase the Zn21 IC50 by 2±25-fold, while the R244G
E266A 98 6 2 85 6 4 3 mutation results in a 35-fold decrease in Zn21 IC50. The
E266S 98 6 2 90 6 4 3 mutations H44A, H128S, K233R, and E266S have a more
K270A 40 6 1 nd 3
drastic effect on the Zn21 inhibition: H44A decreasesE271S 45 6 7 33 6 5 3
the apparent Zn21 affinity by 70-fold, H128S by 520-fold,D285S 44 6 5 31 6 4 3
E289Q 41 6 12 nd 7 K233R by 200-fold, and E266S by 425-fold, respectively.
E308Q 41 6 11 nd 8
C320A 49 6 6 32 6 4 3
Controlling for Zn21 Binding Specificity of theE328Q 40 6 12 nd 6
H332S-H335S 43 6 14 nd 6 Mutations Affecting Zn21 Inhibition
E352P-E353G 49 6 2 31 6 5 3 Our mutagenesis scan resulted in the identification of
H358A 56 6 6 38 6 5 5 four residues, H44, H128, K233, and E266, whose muta-
E371Q 38 6 11 nd 6
tion profoundly affects the apparent affinity of the inhibi-E373A 34 6 3 23 6 2 2
tory Zn21 binding site. The nature of these residues (ex-K374S 85 6 6 63 6 10 6
cept for the lysine, but see Discussion), as well as theH387S 38 6 9 29 6 3 6
C399A 41 6 5 nd 3 amplitude of the mutation-induced shifts in Zn21 IC50
(between 70- and 500-fold), supports the idea that theySubstitution of H, C, D or E residues and positively charged K or R
may directly participate in the high-affinity Zn21 bindingresidues within the NR2A LIVBP-like domain were tested. Con-
structs and figures that differ from NR2A2wt by . 1.25-fold are in site. However, a strong effect of a mutation on the IC50
bold; those that differ by . 2-fold are underlined. is not a proof that the residue participates in the binding
process. Indeed, mutations that affect the gating equi-
librium (hereinafter called remote to distinguish them
from mutations that directly affect Zn21 binding) mayor underlined in Figure 3 and Table 1, respectively).
ªModeratelyº affected mutants were defined as those reciprocally affect the ligand binding equilibrium (Col-
quhoun, 1998). Quantitatively, the effects of such remotethat had relative currents larger or smaller than those
of wild type by .1.25-fold and ,2-fold (simply bold in mutations can be large.
Two mutations in the P loop region (TM2) of the NR1Figure 3 and Table 1). Of the 45 positions mutated, all of
which gave functional receptors, our screening strategy subunit, W590C and N598C, constitute typical examples
of such remote mutations with regard to the high-affinitydetected 11 mutations (H42A, H44A, D78A, H128S,
D207A, E211Q, K233R, R244G, E266S, H358A, and Zn21 binding site. NR1-W590 has been located in the
inner vestibule of the channel (Kuner et al., 1996), andK374S), resulting in a significant modification of the Zn21
inhibition with four mutants, H44A, H128S, K233R, and NR1-N598 is part of the selectivity filter, deep in the
pore, where blocking Mg21 ions bind (see Dingledine etE266S, that could be classified as strongly affected.
Complete Zn21 inhibition curves were constructed for al., 1999). The locations of these residues make it very
improbable that they participate in the high-affinity Zn21these 11 mutants (see Figure 4 for H44A, H128S, K233R,
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Table 2. Parameters of Voltage-Independent Zn21 Inhibition Curves in Wild-Type and Mutant Receptors
NR2 Construct IC50, nM Imax nHill n
a NR2Awt 16 6 6 0.77 6 0.02 0.87 6 0.17 11
b NR2Cwt 25000 6 5000 0.97 6 0.03 0.73 6 0.05 9
c NR2A-H44A 1100 6 100 0.78 6 0.03 1.64 6 0.36 7
d NR2A-H128S 8300 6 600 0.96 6 0.03 1.13 6 0.07 4
e NR2A-K233R 3100 6 300 0.82 6 0.04 0.90 6 0.12 3
f NR2A-E266S 6800 6 600 0.99 6 0.01 1.07 6 0.15 3
g NR2A-E266A 1400 6 500 0.80 6 0.05 0.84 6 0.13 3
h NR2A-H42A 180 6 30 0.85 6 0.03 1.00 6 0.05 4
i NR2A-D78A 210 6 40 0.81 6 0.03 0.79 6 0.12 5
j NR2A-D207A 170 6 80 0.84 6 0.10 0.65 6 0.08 10
k NR2A-E211Q 80 6 50 0.79 6 0.02 0.70 6 0.05 6
l NR2A-H358A 32 6 3 0.81 6 0.01 0.82 6 0.08 3
m NR2A-K374S 400 6 90 0.82 6 0.05 0.72 6 0.06 4
n NR2A-R244G 0.46 6 0.10 0.80 6 0.01 1.15 6 0.16 3
o NR2A-H42A-H44A 2600 6 400 0.88 6 0.06 2.03 6 0.49 3
p NR2A-H42A-H44A-E266A 4000 6 300 0.92 6 0.04 1.39 6 0.03 2
The parameters for wild-type NR2 constructs are shown in rows a and b. Those for NR2A showing a large decrease, a moderate decrease,
or an increase in their apparent affinity for Zn21 are shown in rows c to g, h and m, and n, respectively. Rows o and p correspond to multiple
mutations.
inhibitory site, which, given the lack of voltage depen- Table 3 shows the parameters of equation 3 used to fit
the curves (see Experimental Procedures). A compari-dence of the Zn21 inhibition, must be outside the trans-
membrane field. Indeed, the mutation NR2A-N595K, son with wild type shows no significant variation in the
fitting parameters of the five NR2A mutants. In contrast,which introduces a positive charge in the selectivity filter
(i.e., in the close vicinity of NR1-N598), fully prevents the two remote NR1 mutants have a 10-fold greater
affinity for both glycine and glutamate relative to wildaccess to the pore for divalent cations but leaves unaf-
fected the high-affinity Zn21 inhibition (see Paoletti et type.
Extracellular protons in the physiological concentra-al., 1997). Despite their probable distance from the Zn21
binding site, the mutants NR1-W590C and NR1-N598C, tion range (zpH 7) have been shown to inhibit NMDA
receptors via a decrease in their open probabilitycoexpressed with NR2Awt, both strongly decrease Zn21
inhibition. The amplitudes of the relative current, mea- (Traynelis and Cull-Candy, 1990). Residues from differ-
ent parts of the extracellular domains of NR1 subunitssured at 260 mV in the presence of 0.5 mM Zn21 in
the bath (0.92 6 0.04, n 5 4, and 0.85 6 0.05, n 5 3, appear to be involved in this modulation (see Dingledine
et al., 1999). Proton inhibition curves obtained from re-respectively), are comparable to those of the strong
mutants (see Table 1). In fact, mutations at position NR1- ceptors containing each of the strong NR2A mutants
(H44A, H128S, K233R, and E266S) were not much, if atN598 have already been shown to have pleitropic effects
on gating (Schneggenburger and Ascher, 1997), sperm- all, different from those of wild-type receptors (Figure
5A). In contrast, NR1-W590C and NR1-N598C mutationsine potentiation, and proton (Kashiwagi et al., 1997;
Traynelis et al., 1998; Zheng et al., 1999) and Zn21 induced a significant increase in proton IC50 (7- and
4-fold, respectively; Figure 5A). Three of the tested mod-(Traynelis et al., 1998) inhibition.
How can one distinguish a mutation in the Zn21 bind- erate NR2A mutants (H42A, D207A, and K374S) showed
proton inhibition curves that were indistinguishable froming site from a remote one? Remote mutations should
nonspecifically affect the binding of other ligands acting those of wild-type receptors (data not shown). However,
the mutation NR2A-R244G induced a 2-fold decreaseon gating, whereas a mutation of the Zn21 binding site
has a much higher probability of specifically affecting in proton IC50 (Figure 5A).
Extracellular Ni21 ions, in addition to inducing a volt-Zn21 inhibition (except, of course, if the mutated residue
also participates in the gating mechanism). To test the age-dependent block very similar to that of Mg21, also
inhibit in a voltage-independent manner several recom-specificity for Zn21 inhibition of the four strong mutations
and of several moderate mutations that had been identi- binant NMDA receptor subtypes (those containing
NR2A, NR2B, or NR2D subunits; P. Paoletti and J. N.,fied, we compared the effects of these mutations with
those of two remote mutations (NR1-W590C and NR1- unpublished data). As for protons, Ni21 inhibition curves
of receptors containing the strong NR2A mutants didN598C) on several gating modulations of NMDA recep-
tors: (1) the activation by the agonists glutamate and not significantly differ from those of wild-type receptors
(for NR2A-H44A and NR2A-H128S, only one concentra-glycine, (2) the inhibition by extracellular protons, and
(3) the voltage-independent inhibition by extracellular tion of Ni21 was tested [100 mM], and the relative currents
were close to those of wild-type receptors: 0.42 6 0.03,Ni21 ions.
Dose±response curves for glutamate and glycine were n 5 3, for H44A; 0.55 6 0.04, n 5 3, for H128S; 0.52 6
0.06, n 5 5, for wild type). In contrast again, both NR1-obtained under Zn21-free conditions for receptors con-
taining NR1wt and NR2Awt subunits, receptors con- W590C and NR1-N598C mutations induced a 5-fold in-
crease in Ni21 IC50. The moderate NR2A mutant R244Gtaining NR1wt and one of the NR2A mutants (H44A,
H128S, K233R, R244G or E266S), and receptors con- did not affect Ni21 sensitivity (with 100 mM Ni21, the
relative current was 0.55 6 0.07, n 5 7).taining either NR1-W590C or NR1-N598C and NR2Awt.
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Table 3. Parameters of Glutamate and Glycine Activation Curves of Wild-Type and Mutant Receptors
Glutamate Glycine
Construct EC50, mM nHill EC50, mM nHill
NR1wt/2Awt 5.9 6 0.5 1.4 6 0.1 1.4 6 0.4 1.5 6 0.1
NR1wt/NR2A-H44A 4.4 6 1.0 1.4 6 0.1 1.3 6 0.1 1.5 6 0.1
NR1wt/NR2A-H128S 3.8 6 0.9 1.3 6 0.1 1.3 6 0.1 1.5 6 0.1
NR1wt/NR2A-K233R 6.0 6 0.4 1.4 6 0.1 1.5 6 0.3 1.7 6 0.3
NR1wt/NR2A-E266A 5.9 6 0.5 1.4 6 0.1 1.5 6 0.3 1.9 6 0.3
NR1wt/NR2A-R244G 3.7 6 0.3 1.3 6 0.1 1.9 6 0.1 1.5 6 0.1
NR1-W590C/NR2Awt 0.54 6 0.06 1.5 6 0.3 0.17 6 0.02 1.8 6 0.3
NR1-N598C/NR2Awt 0.47 6 0.08 1.5 6 0.2 0.29 6 0.02 2.6 6 0.4
Responses were recorded at a steady negative voltage (230 mV or 260 mV) with solutions containing 10 mM tricine and 10 mM DTPA but
no added Zn21 (Zn21-free conditions) in three different oocytes for each construct, except for the glycine activation curve of NR1wt/NR2A-
E266A, which was obtained in two cells only.
Discussion voltage-independent Zn21 inhibition. The four most ef-
fective mutations were only able to shift the Zn21 IC50
into the low micromolar range, which is on the samePrevious studies (Williams, 1996; Chen et al., 1997;
order as the Zn21 affinity of non-NR2A-containing re-Paoletti et al., 1997; Traynelis et al., 1998) have shown
combinant receptors (z1 mM for NR2B, see Williams,that the voltage-independent inhibition of NMDA recep-
1996; Chen et al., 1997; Paoletti et al., 1997; Traynelistors by extracellular Zn21 depends on the subtype of the
et al., 1998; z20 mM for NR2C, see Paoletti et al., 1997;NR2 subunit present, with receptors containing NR2A
Traynelis et al., 1998; and z2 mM for NR2D, A. F. andsubunits having a remarkably high apparent affinity for
J. N., unpublished data). One possible explanation forZn21 (IC50, z20 nM). This work aimed at identifying the
these observations is that there is a single inhibitorymolecular determinants of the high-affinity Zn21 binding
Zn21 binding site in each subtype of the NR2 subunitsite. Given the voltage independence and the subunit
and that these sites share conserved amino acids atspecificity of the Zn21 inhibition, we hypothesized that
homologous locations. In this case, the residues specificthe high-affinity Zn21 binding site should be located in
to NR2A (for example, H44) would be the ones thatan extracellular domain of the NR2A subunit, and indeed
confer high affinity to the Zn21 binding site. The low-found that the presence of the the LIVBP-like domain
affinity Zn21 binding site would be made up of residuesof NR2A is required and sufficient to confer high-affinity
partly conserved across NR2 subtypes (e.g., H128,Zn21 inhibition to receptors expressing chimeric NR2A/
K233, or E266). Under this scheme, as recently proposedNR2C subunits. This, combined with the fact that dele-
by Choi and Lipton (1999), the binding site could retain ation of this domain does not prevent expression of func-
basal level of affinity for Zn21 even if one of the importanttional receptors (see Figure 2), strengthens the proposal
residues is mutated. If this were the case, mutating thethat the N-terminal region preceding the agonist binding
nonconserved residue, H44, along with a conserveddomain constitutes a modular domain involved in gating
residue should produce additive effects on apparentmodulation (KoÈ hr et al., 1994; Krupp et al., 1998; Vil-
Zn21 affinity. This is not the case, as shown with thelarroel et al., 1998; Masuko et al., 1999). A point muta-
triple mutant NR2A-H42A-H44A-E266A (see Table 2),genesis scan through the LIVBP-like domain of NR2A
which has an IC50 very close to that of NR2A-H44A andallowed us to identify several residues that, when mu-
NR2-E266A mutants. Moreover, receptors made withtated, severely affected high-affinity Zn21 inhibition. The
NR2A subunits lacking the entire LIVBP-like domainamplitude and specificity of the effects of individual
[NR2A9(DN1±3)tr; see Figure 2, last row] retain an affinitypoint mutations on the Zn21 inhibition favor four resi-
for Zn21 in the low micromolar range, not significantlydues, two histidines (H44 and H128), a lysine (K233),
different from the affinity of receptors containing theand a glutamate (E266) as being closely associated with
most effective mutations. The possibility remains thatthe high-affinity Zn21 inhibitory site. Another study, pub-
another domain, located elsewhere on the receptor,lished while this work was in progress (Choi and Lipton,
forms a low-affinity site that is transformed into a high-1999), already proposed that one of these residues,
affinity site in the presence of the LIVBP-like domain.NR2A-H44, together with NR2A-H42, constitutes part of
As we shall see in the next paragraph, this is unlikely.the high-affinity Zn21 binding site. As discussed below
Based on the two arguments presented above, we(third section of Discussion), we agree with this proposal
favor the following alternative explanation: (1) all NMDAfor NR2A-H44 but suggest another interpretation for the
receptor types possess a low-affinity Zn21 inhibitory site;role of NR2A-H42.
(2) those containing NR2A have an additional high-affin-
ity site; and (3) in NR2A-containing receptors, Zn21 occu-
NR2A-Containing NMDA Receptors May Possess pancy at both sites leads to partial inhibition through
Two Types of Voltage-Independent Zn21 mechanisms that converge at some point. Under this
Inhibitory Sites hypothesis, the low-affinity Zn21 binding site of NR2A
Even though several mutations in the NR2A N terminus normally would be masked by the high-affinity site be-
were able to shift Zn21 affinity by several orders of mag- cause the receptors could be already maximally inhib-
ited at concentrations of Zn21 much lower than thosenitude, none of them were able to completely eliminate
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needed to activate the low-affinity site. However, when
the high-affinity Zn21 binding site is perturbed, either by
one of the four strong NR2A mutations or by deletion
of the NR2A LIVBP-like domain, the low-affinity binding
site is unmasked, and in these constructs the Zn21 IC50
reflects that of the low-affinity site. In addition to the
strikingly similar shifts in Zn21 IC50 induced by each
strong mutation and by the deletion construct, support
for this interpretation is provided by the fact that the Zn21
inhibition dose±response curve of NR1-N598C/NR2Awt
receptors is biphasic at 150 mV (data not shown), with
a minor high-affinity component (IC50, z20 nM) that satu-
rates at 85% of the control current and a major low-
affinity component (IC50, z7 mM) that saturates at 20%
of the control current. These results, showing the simul-
taneous presence of two different Zn21 binding sites in
receptors containing wild-type NR2A but mutated NR1
subunits, argue strongly for the potential presence in
NR2A-containing receptors of two Zn21 binding sites
with differing affinities for Zn21. So far, we have found no
NR2A mutants inducing a Zn21 IC50 increase significantly
larger than that observed with the N1±3 deletion mutant.
Therefore, the sole indication regarding the localization
of the potential low-affinity Zn21 binding site is that it
must be outside the NR2A LIVBP-like domain, whether
in the extracellular domains of NR1 or in the agonist
binding domain of NR2A.
Figure 5. Voltage-Independent Inhibition Due to Either H1 or Ni21
Specificity of the Effects of Mutations on Zn21Ions Is Not Affected by Mutations at NR2AH44, NR2AH128,
NR2AK233, and NR2AE266 Inhibition and Convergence of NMDA
Receptor Modulations(A) The responses of oocytes expressing each of the strong NR2A
mutants, as well as wild type, two NR1 pore mutants, and one Zn21 inhibits NMDA receptors by reducing the open
moderate NR2A mutant receptor were recorded at different pH val- probability of activated receptors (Christine and Choi,
ues and at 260 mV in the absence of Zn21 (10 mM tricine and 10 1990; Legendre and Westbrook, 1990), i.e., voltage-
mM DTPA were present in all solutions). The experimental points
independent binding of Zn21 on extracellular bindingwere fitted with equation 2 (see Experimental Procedures), giving
sites results in changes in some of the conformationalthe following values for the fitting parameters (pHI50 and nH, respec-
equilibria involved in the gating mechanism. Micro-tively): 6.8 and 1.6 for NR1wt/NR2Awt (closed circles), 6.8 and 1.6
for NR1wt/NR2A-H44A (open squares), 6.7 and 1.5 for NR1wt/NR2A- scopic reversibility in thermodynamic equilibria implies
H128S (closed diamonds), 6.7 and 1.4 for NR1wt/NR2A-K233R (open that if binding of Zn21 modifies certain gating equilibria,
circles), and 6.7 and 1.4 for NR1wt/NR2A-E266S (closed upside- modifications of these gating equilibria should reversibly
down triangles). The curves for the strong mutants were not very affect Zn21 binding, and, therefore, a decrease in appar-
different from that obtained with wild-type receptors. In contrast,
ent affinity for Zn21 could result from modifications inthe pH±response curves for the pore mutants NR1-W590C/NR2Awt
the gating mechanism, as well as from perturbations of(open upside-down triangles) and NR1-N598C/NR2Awt (closed
the Zn21 binding site itself. However, whereas the firstsquares) showed markedly less sensitivity to protons (pHI50 and nH
were 6.0 and 2.0, 6.2, and 1.9, respectively), whereas the pH curve mechanism is expected to alter the effects of other
of the moderate mutant NR1wt/NR2A-R244G (open diamonds) agents acting on gating, the second should specifically
showed a clear increase in proton sensitivity (pHI50 5 7.1 and nH 5 affect Zn21 inhibition. The four NR2A strong mutations
1.7). identified in this study (H44A, H128S, K233R, and E266S)
(B) The Ni21 sensitivity of a similar series of NMDA receptors was
do not appear to affect the gating mechanism itselfmeasured with Ni21-buffered solutions (see Experimental Proce-
because in receptors containing these mutations, Ni21dures). Current measurements were made at the end of a 4 s voltage
inhibition or (in the absence of Zn21) activation by gluta-ramp from 2100 mV to 150 mV to avoid contamination of the Ni21
voltage-independent inhibition by Ni21 voltage-dependent block. mate and glycine (see Table 3) and voltage-independent
Experimental points were fitted by equation 1, imposing nH 5 1. inhibition by extracellular protons (Figure 5) are similar
Symbols as in (A), except for closed upside-down triangles, which to those recorded in wild-type receptors. This indicates
correspond to NR1wt/NR2A-E266A receptors. Dose±response that, within the chain of events linking Zn21 binding to
curves for NR1wt/NR2Awt and two of the strong mutant receptors,
the decrease in open probability, these mutations mustNR1wt/NR2A-K233R and NR1wt/NR2A-E266A, are very similar (IC50
affect either the Zn21 binding reaction itself or a stepand maximal inhibition being, respectively, 99 mM and 0.92 for
very close to it. Many other mutations affect high-affinityNR2Awt, 97 mM and 0.85 for NR2A-K233R, and 82 mM and 0.89
for NR2A-E266A). For NR1wt/NR2A-H44A and NR1wt/NR2A-H128S Zn21 inhibition, and several of them are not located in the
receptors, only one Ni21 concentration was tested (see text). The NR2A LIVBP-like domain. Interestingly, most of these
Ni21 dose±response curves for NR1-W590C/NR2Awt and NR1- mutation were first identified as affecting gating modula-
N598C/NR2Awt receptors showed a decreased apparent affinity tors other than Zn21 (NR1-E342Q and NR1-D669N, which
(550 mM and 500 mM, respectively) and a lower maximal inhibition
decrease proton sensitivity [Williams et al., 1995; Kashi-(0.70 and 0.60, respectively).
wagi et al., 1996; Traynelis et al., 1998]; NR1-C744A
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and NR1-C798A, which decrease sensitivity to reducing (10 nM±10 mM), are present in several ligand-gated
channels, including members of the GABAA (Wooltortonagents [Sullivan et al., 1994]). This also appears to be
et al., 1997; Horenstein and Akabas, 1998), glycinethe case for two other mutations described in this paper,
(Laube et al., 1995), and ATP (Li et al., 1997) families ofNR1-W590C and NR1-N598C, both of which are located
ligand-gated channels, and in most cases have not beenin the putative P loop of NR1. Both mutations have
well characterized. A histidine residue located in thepleiotropic effects on Zn21 inhibition, and glutamate and
second transmembrane segment of GABAA subunits hasglycine activation (Table 3), as well as on inhibition due
been implicated in the voltage-independent Zn21 inhibi-to protons and Ni21 (Figure 5). Strikingly, mutations of
tion of GABAA receptors (Wooltorton et al., 1997; Hor-the homologous residues of the NR2A subunit (W587,
enstein and Akabas, 1998). Two recent studies haveN595, and N596) do not perturb the high-affinity Zn21
implicated histidine residues in the sequence H-X-H asinhibition (A. F. and J. N., unpublished data), suggesting
forming part of the Zn21 inhibitory binding site in glycinethat the involvement of pore residues in the gating mech-
(Harvey et al., 1999) and NMDA receptors (Choi andanism is specific to NR1 subunits.
Lipton, 1999; our work, however, is not in full agreementWithin the NR2A LIVBP-like domain, several muta-
with this interpretation, as discussed below).tions having moderate effects on Zn21 inhibition were
In this paper, we show that several residues in thetested for Zn21 inhibition specificity. Some of these, all
NR2A LIVBP-like domain are important for high-affinityof which reduce sensitivity to Zn21, were found to be
Zn21 inhibition, and of these, four residues, H44, H128,without effect on proton inhibition (H42A, D207A, and
K233, and E266, appear closely associated with the Zn21E211Q; data not shown). However, R244G, which in-
binding site because of the large shift in Zn21 affinityduces a marked increase in Zn21 sensitivity (see Tables
and specificity for Zn21 inhibition of mutations at these1 and 2), also raised the sensitivity to protons (Figure
residues. Given the nature of their side chains, H44,5A) but did not affect glutamate and glycine activation
H128, and E266 may directly coordinate Zn21 or, alterna-curves (Table 3). The fact that mutations in the NR2A
tively, help in shaping the three-dimensional structureLIVBP-like domain can lead to either specific effects on
of the Zn21 binding site by holding coordinating groupsZn21 inhibition or pleiotropic effects on different gating
in correct position. The second interpretation is the mostmodulations is not surprising. ªSpecificº residues could
intuitive explanation for the large effect of a positivelybe participating in shaping the three-dimensional struc-
charged amino acid like K233. However, participationture around Zn21-coordinating residues. ªPleiotropicº
of lysine as a direct coordinating group has been demon-residues may affect gating modulation at a point distant
strated in the binuclear metal centers of several Zn21- orfrom the Zn21 binding step itself, for example, at the
Ni21-containing enzymes. Two mechanisms have beeninterface of the LIVBP-like domain and the remainder
advanced as explanations of this counterintuitive phe-of the protein. In this regard, it is worth pointing out that
nomenon. In the first one, the e amine of the lysine isthe NR2A LIVBP-like domain was recently identified as
carbamylated, i.e., the positively charged amine groupone of the major determinants of Ca21- and glycine-
is modified to a negatively charged carbamate groupindependent desensitization (Krupp et al., 1998; Vil-
upon reaction with carbon dioxide (Volbeda et al., 1996).larroel et al., 1998). Zn21 binding itself is not required
In some cases, this reaction requires the presence offor desensitization because receptors desensitize even
chaperone proteins (Park and Hausinger, 1995), and thein the presence of Zn21 chelators (see, e.g., see Paoletti
unstable carbamate group is stabilized by the constitu-et al., 1997; Figure 8). However, the kinetics of the onset
tively bound Zn21 or Ni21 cation. Such a mechanismof desensitization are accelerated by Zn21 (Chen et al.,
appears inappropriate for a modulatory Zn21 binding1997). Thus, Zn21 inhibition and desensitization may
site, where occupancy by the metal cation must be tran-converge on a common step of the gating process with,
sient. In the second mechanism, the unprotonated formfor example, Zn21 binding leading to stabilization of a
of the e amine coordinates the divalent ion (Burley et
desensitized state. Analyzing the effects on desensitiza-
al., 1992; Buy et al., 1996). To achieve deprotonation
tion of the NR2A mutants identified in this study may
of the lysine lateral chain (usual pKa, z10), a two-stephelp to clarify this point. binding process may occur in which the divalent metal
binds first to other ªclassicº determinants of the binding
Are H44, H128, K233, and E266 Making the site (like histidines), bringing the divalent cation close
High-Affinity Zn21 Binding Site in the NR2A to the e amine deprotonating it. The deprotonated amine
LIVBP-like Extracellular Domain? would then bind to the metal ion. This mechanism seems
Zn21 binding sites have been characterised in many met- more appropriate for accounting for the reversible Zn21
alloproteins in which the Zn21 ion participates in cataly- binding on modulatory sites. In the NR2A LIVBP-like
sis or helps to stabilize the three-dimensional conforma- domain, H44 and H128 (and possibly E266) may be the
tion of the peptide chain (Lippard and Berg, 1997). At determinants involved in the first step, allowing ap-
these sites, Zn21 is tightly bound, with an affinity in the proach of K233 by the partly coordinated Zn21 ion.
picomolar to nanomolar range. X-ray diffraction studies In contrast with Choi and Lipton (1999), our data sug-
have shown that Zn21 is usually coordinated in a tetrahe- gest a modest role for NR2A-H42 at the high-affinity
dral, square planar, or octahedral geometry by at least Zn21 binding site. The mutant H42A produces a moder-
three amino acid ligands, which often include a doublet ate shift in Zn21 IC50 (11-fold). Choi and Lipton (1999)
of cysteines or histidines seperated by a short spacer observed a much larger shift (211-fold) with the mutation
(Christianson, 1991; Glusker, 1991; Vallee and Auld, NR2A-H42G. Participation of both H42 and H44 seems
1993; Karlin and Zhu, 1997). Modulatory Zn21 binding appealing given the frequency of shortly spaced histi-
dines known to occur in Zn21 binding sites. However, ifsites, where Zn21
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sequences. In NR2A/C(553), the N-terminal region of NR2A, up toH42 were participating in Zn21 coordination, substitution
P552, is followed by the NR2C sequence starting at Y564 (switchof the histidine by alanine should result in a Zn21 binding
at position 553). In NR2C/A(564), the switch is between NR2C-P563perturbation as large as that due to substitution by gly-
and NR2A-F553 (five hundred and sixty-fourth position). In
cine. We therefore propose that H42 does not directly NR2C(AN1±4), the switch is between NR2A-E413 and NR2C-R424.
coordinate the Zn21 ion. Due to its very close proximity The other chimeras used in this study have been generated using
NR2A9 as the receiving subunit. NR2A9 differs from wild-type NR2Ato H44, it may be involved in the correct positioning of
in two respects: first, the four residues just preceeding TM1 (F553±H44 with regard to H128. Indeed, such a role for a shortly
S556 in NR2A) have been replaced by their NR2C homologs (Y564±spaced histidine residue in the Zn21 center of alkaline
A567); second, two nonsilent restriction sites have been introduced,phosphatase serves just such a function by forming a
leading to the mutations K221Q, I222V, S384Y, and L385M. Borders
hydrogen bond that helps to correctly position a Zn21- of the different N1a±N6 N-terminal regions are as follows (given in
coordinating residue (Kim and Wyckoff, 1991). H42G NR2A/NR2C amino acid position): K138/K146 end of N1a, L219/
L229 end of N1b (and N1), T342/T352 end of N2, L383/L393 end ofmost likely introduces a much larger steric change than
N3, E413/E423 end of N4, K465/K476 end of N5, and P552/P563H42A does, and thus possibly a larger displacement of
end of N6. In all deletion constructs, the NR2A N-terminal signalH44.
sequence was conserved. In addition to the N-terminal deletion ofWhatever the actual role of the four potential determi-
the N1±N3 segments, the deletion construct NR2A9(DN1±3)tr has a
nants of the Zn21 binding site (coordination or local deletion of part of the C-terminal introduced by insertion of a stop
structure), they must be located close to each other in codon at position NR2A9-K1116.
Heterologous Expression of NMDA Receptorsthe three-dimensional structure of the LIVBP-like do-
in Xenopus Oocytesmain. There is no available structural data for the LIVBP-
Twenty nanoliters of a mixture of NR1 and NR2 plasmids (ratio oflike domain of ionotropic glutamate receptors, unlike
1/2) at a final concentration of 10 ng/ml was injected into the oocytethe ligand binding domain, which has been purified
nuclei. Oocytes were prepared and kept as described in Paoletti et
and crystallized in the case of GluR2 (Armstrong et al., al. (1995) and recorded 1±5 days following DNA injection. Most of
1998), an AMPA glutamate receptor. However, the three- this work consisted of the functional characterization of chimeric
or mutant NR2 subunits. In the Xenopus oocyte, heterologous ex-dimensional structures of different members of the bac-
pression of the recombinant NR1 subunit only has been shown toterial LIVBP family have been solved. LIVBP consists of
result in measurable glutamate responses (homomeric NR1 re-two lobes connected via a hinge to form a gorge con-
sponses) due to activation of receptors made from heterologoustaining the amino acid binding site. The amino acid binds
NR1 subunits associated with endogenous Xenopus NR subunits
to residues contributed by each of the two lobes, pro- (see Soloviev et al., 1996). All of our NR2 constructs were tested
moting closure of the gorge. Given their scattered local- by coexpression with wild-type NR1 subunits. We were therefore
concerned by the possibility that some of our chimeric or mutantization along the LIVBP-like domain sequence, a tempt-
NR2 constructs might not be functional and might display a homo-ing hypothesis is that all four residues, H44, H128, K233,
meric NR1 phenotype. However, under our experimental conditionsand E266, belong to loops (separating secondary struc-
(0.3 mM Ba21 as the sole external divalent), the amplitude of homo-ture elements) that flank the gorge from both lobes (e.g.,
meric NR1 responses never exceeds 50 nA at 260 mV, even 5 days
lobe 1 for H44 and H128 and lobe 2 for K233 and E266). after cDNA injection. All of the NR2 constructs tested in this study,
Such a localization would allow an appealing mecha- except NR2A9(CN1) (see Results), induced responses that were at
least 5-fold larger than the largest homomeric NR1 response. Wenism for Zn21 inhibition in which Zn21, by binding to
thus conclude that all of these constructs participated in the forma-determinants on both lobes, might promote the closure
tion of functional NR1/NR2 receptors.of the gorge. If such a hypothesis were experimentally
verified, a further step in understanding the Zn21 inhibi-
Buffering Solutions for Zn21, Ni21, and H1
tion mechanism could be to identify the interaction do- Zn21-Buffered Solutions
mains that signal to the rest of the protein the change of NMDA receptors containing NR2Awt have such a high affinity for
Zn21 that they are tonically inhibited by trace concentrations ofconformation associated with the closure of the gorge.
contaminating Zn21 in standard solutions (Paoletti et al., 1997). In
order to make Zn21 inhibition dose±response curves in the submi-
Experimental Procedures cromolar range, the Zn21 concentration must be buffered using che-
lators of moderate affinity. Tricine (N-tris[hydroxymethyl]methylglyc-
NMDA Receptor Subunit Constructs ine) with the constants K1 5 1025 M for the equilibrium M 1 L $
and Heterologous Expression ML and K2 5 1023 M for the equilibrium ML 1 L $ ML2 (Vieles et
Wild-Type and Mutant Constructs al., 1972; see also Paoletti et al., 1997) was added at 10 mM to
The pcDNA3 expression plasmids for rat NR1a (hereinafter simply buffer Zn21 in the range 1 nM±1 mM. ADA (N-[2-acetamido]iminodia-
referred to as NR1), NR2A, and NR2C subunits have been described cetic acid) with K1 5 1027.3 M and K2 5 1022.2 M (Martell and Smith,
in Paoletti et al. (1997). Point mutations were produced according 1989) was added at 1 mM to buffer Zn21 in the 0.05±100 nM range.
to the method of Kunkel (1985). For each mutation, at least two Geochem, a multipurpose chemical speciation program (Parker et
independent clones were isolated in which the presence of the al., 1995), was used to establish the relationship between the con-
mutation was verified by sequencing across the mutated region centrations of free and total Zn21 contained in the buffered solutions
(z50 bp on either side of the mutation). For those mutations resulting ([Zn]f and [Zn]t, respectively). Equilibria taken into account were the
in a phenotype that differed from wild type (according to our Zn21 ones between chelators and Zn21, chelators and protons, and Zn21
inhibition screening procedure; see Results), the two independent and OH2 (equilibria between Zn21 and either glutamate or glycine,
clones were functionally characterized to confirm that the modified both present at 100 mM, were neglected). At pH 7.3 and with 10
phenotype resulted from the planned mutation rather than from a mM tricine, calculations show that there is a linear relation, [Zn]f 5
stray mutation produced during the mutagenesis process. [Zn]t/200 for [Zn]f , 1 mM. A linear relation, [Zn]f 5 [Zn]t/17000, was
Chimeric Constructs also found at pH 7.3 with 1 mM ADA for [Zn]f , 3 nM; for larger [Zn]f
Most of the NR2A/NR2C chimeras used in this study have already (10, 30, and 100 nM), calculated [Zn]t were 150, 350, and 640 mM,
been described in Villarroel et al. (1998). They were obtained by respectively. For all Zn21 inhibition dose±response curves, a Zn21-
swapping homologous domains from one subunit into the other free reference solution was made by adding 10 mM DTPA (diethyl-
after introducing convenient restriction sites by PCR. NR2A/C(553), enetriamine-pentaacetic acid, a strong Zn21 chelator, Kd 5 10215.6
M) to the zero-added Zn21-buffered solution.NR2C/A(564), and NR2C(AN1±4) contain only wild-type amino acid
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Ni21-Buffered Solutions for Zn21 and Ni21 inhibitions (x is the Zn21 or Ni21 concentration, a
is the maximal inhibition, and n is the Hill coefficient),Ni21 inhibition in NR2A-containing receptors requires submillimolar
Ni21 concentrations. With such high Ni21 concentrations, complexes
f(x) 5 1/[1 1 (10pH 2 pHI50)n] (2)between Ni21 and glutamate or glycine must be taken into consider-
ation. Using Geochem (with K1 5 1025.6 M and K2 5 1024.2 M for for proton inhibition, and
glutamate, K1 5 1025.75 M and K2 5 1024.85 M for glycine), we calcu-
lated total concentrations of Ni21, glutamate, and glycine that were f(x) 5 1/[1 1 (EC50/x)n] (3)
appropriate to obtain a constant 100 mM concentration for free
for glutamate and glycine activation curves (f[x] is the relative currentglutamate and glycine, and three different concentrations of free
normalized to the maximum current recorded at saturating 100 mMNi21, 10 mM, 100 mM, and 1 mM. For the three cases, the calculated
concentrations of both agonists, x is the concentration of the testedconcentrations were (in mM): 101, 110, and 190 for glutamate; 102,
agonist, the other one being present at 100 mM, and n is the Hill122, and 310 for glycine; and 13, 130, and 1300 for Ni21. For each
coefficient). In fitting the glycine activation curves, errors potentiallytested concentration of Ni21, a control solution without agonist was
introduced by contaminating glycine (Johnson and Ascher, 1987)obtained by simply adding Ni21 at the final desired concentration
were eliminated by restricting the fit to experimental points obtainedto our normal control solution.
with at least 300 nM glycine. In Table 2, inhibition curves for eachpH-Buffered Solutions
individual oocyte were fitted, and the value was given for IC50; maxi-In the proton inhibition experiments, 5 mM MES (2[N-morpholino]
mal inhibition and Hill coefficient are mean 6 SD, calculated fromethanesulfonic acid, pKa 5 6.1), 5 mM HEPES (N-[2-hydroxyethyl]
parameter values of the individual fits. Table 3 was constructed inpiperazine-N9-[2-ethane-sulfonic acid], pKa 5 7.5), and 10 mM tricine
the same way.(pKa 5 8.2) were present in the bath solutions to allow pH buffering
on a wide range (5.8±8.3). pH was adjusted with NaOH. DTPA (10
AcknowledgmentsmM) was added to all solutions used in proton inhibition experiments
in order to achieve Zn21-free conditions. Agonists were used at
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